Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer

Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that can attack cancer.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive